Microbot Medical
MBOT
34 hedge funds and large institutions have $3.11M invested in Microbot Medical in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 6 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
3% more funds holding
Funds holding: 33 → 34 (+1)
8% less capital invested
Capital invested by funds: $3.39M → $3.11M (-$285K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$1.07M |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$228K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$115K |
| 4 |
BCM
Bourgeon Capital Management
Darien,
Connecticut
|
+$43.8K |
| 5 |
KA
Kovack Advisors
Ft. Lauderdale,
Florida
|
+$43.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$77K |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
-$61K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$40.1K |
| 4 |
D.E. Shaw & Co
New York
|
-$18K |
| 5 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$9.51K |
MBOT Hedge Fund Activity: Q1 2016 in Review
34 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2016, worth a combined $3.11M — down 8.4% from $3.39M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new MBOT positions and 6 closed out — a net gain of 1 holder — while 7 added to existing stakes and 5 trimmed.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $1.07M. The largest seller was Sabby Management, exiting entirely with an estimated $77K sold.
- 34 institutional investors held Microbot Medical (MBOT) as of Q1 2016, up from 33 in Q4 2015.
- Funds reported $3.11M of Microbot Medical stock for Q1 2016, down 8.4% quarter-over-quarter.
- 7 funds opened new Microbot Medical positions in Q1 2016 and 6 closed out, a net change of +1 holder.
- The largest Microbot Medical buyer in Q1 2016 was Anson Funds Management, an estimated $1.07M added.
- The largest Microbot Medical seller in Q1 2016 was Sabby Management, an estimated $77K sold.
Based on aggregated 13F filings for Q1 2016.